Concepts (85)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Candida | 8 | 2023 | 24 | 2.390 |
Why?
|
| Candidemia | 5 | 2020 | 13 | 1.770 |
Why?
|
| Drug Resistance, Fungal | 5 | 2021 | 13 | 1.130 |
Why?
|
| Sepsis | 3 | 2023 | 102 | 1.110 |
Why?
|
| Carbapenem-Resistant Enterobacteriaceae | 1 | 2023 | 6 | 0.830 |
Why?
|
| Fluconazole | 3 | 2020 | 17 | 0.830 |
Why?
|
| Klebsiella Infections | 1 | 2023 | 13 | 0.820 |
Why?
|
| Amphotericin B | 1 | 2021 | 10 | 0.720 |
Why?
|
| Microsatellite Repeats | 2 | 2020 | 14 | 0.690 |
Why?
|
| Microbial Sensitivity Tests | 5 | 2023 | 198 | 0.670 |
Why?
|
| Candida parapsilosis | 1 | 2020 | 4 | 0.660 |
Why?
|
| Fungal Proteins | 1 | 2020 | 5 | 0.660 |
Why?
|
| Sentinel Surveillance | 2 | 2017 | 115 | 0.620 |
Why?
|
| Antifungal Agents | 4 | 2021 | 40 | 0.580 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2017 | 17 | 0.520 |
Why?
|
| Infant, Newborn | 8 | 2023 | 1479 | 0.520 |
Why?
|
| Communicable Diseases | 3 | 2022 | 62 | 0.470 |
Why?
|
| South Africa | 11 | 2025 | 7596 | 0.450 |
Why?
|
| Candidiasis | 4 | 2018 | 15 | 0.420 |
Why?
|
| Anti-Bacterial Agents | 3 | 2023 | 293 | 0.390 |
Why?
|
| Meningitis | 2 | 2022 | 26 | 0.370 |
Why?
|
| Humans | 13 | 2025 | 14537 | 0.360 |
Why?
|
| Cross-Sectional Studies | 3 | 2025 | 1422 | 0.340 |
Why?
|
| Aspergillus | 2 | 2021 | 2 | 0.330 |
Why?
|
| Triazoles | 2 | 2021 | 20 | 0.330 |
Why?
|
| Klebsiella pneumoniae | 3 | 2023 | 39 | 0.300 |
Why?
|
| Infant | 4 | 2025 | 2244 | 0.300 |
Why?
|
| Azoles | 2 | 2020 | 3 | 0.290 |
Why?
|
| Genotype | 2 | 2020 | 442 | 0.260 |
Why?
|
| HIV Infections | 1 | 2025 | 5097 | 0.260 |
Why?
|
| Child | 5 | 2025 | 2242 | 0.260 |
Why?
|
| Incidence | 2 | 2025 | 685 | 0.230 |
Why?
|
| Male | 6 | 2025 | 6754 | 0.230 |
Why?
|
| Disk Diffusion Antimicrobial Tests | 2 | 2021 | 3 | 0.220 |
Why?
|
| Risk-Taking | 1 | 2025 | 121 | 0.220 |
Why?
|
| Child, Preschool | 3 | 2025 | 1748 | 0.210 |
Why?
|
| beta-Lactamases | 1 | 2023 | 23 | 0.200 |
Why?
|
| Disease Outbreaks | 1 | 2023 | 111 | 0.200 |
Why?
|
| Female | 6 | 2025 | 9103 | 0.200 |
Why?
|
| Surveys and Questionnaires | 1 | 2025 | 563 | 0.190 |
Why?
|
| Bacterial Proteins | 1 | 2023 | 119 | 0.190 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2025 | 262 | 0.190 |
Why?
|
| Perinatal Death | 1 | 2022 | 33 | 0.180 |
Why?
|
| Saccharomycetales | 1 | 2021 | 1 | 0.180 |
Why?
|
| Kluyveromyces | 1 | 2021 | 1 | 0.180 |
Why?
|
| Pichia | 1 | 2021 | 2 | 0.180 |
Why?
|
| Adolescent | 3 | 2025 | 2985 | 0.180 |
Why?
|
| Prevalence | 1 | 2025 | 1192 | 0.170 |
Why?
|
| Viral Load | 1 | 2025 | 819 | 0.170 |
Why?
|
| Voriconazole | 2 | 2018 | 4 | 0.170 |
Why?
|
| Nurseries, Hospital | 1 | 2020 | 1 | 0.170 |
Why?
|
| DNA, Ribosomal Spacer | 2 | 2017 | 9 | 0.170 |
Why?
|
| Amino Acid Substitution | 1 | 2020 | 35 | 0.160 |
Why?
|
| Academic Medical Centers | 1 | 2020 | 30 | 0.160 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2019 | 3 | 0.160 |
Why?
|
| Microsatellite Instability | 1 | 2019 | 5 | 0.160 |
Why?
|
| Phylogeny | 2 | 2017 | 231 | 0.150 |
Why?
|
| Colorectal Neoplasms | 1 | 2019 | 47 | 0.150 |
Why?
|
| Aged | 4 | 2018 | 1740 | 0.150 |
Why?
|
| Middle Aged | 5 | 2019 | 3601 | 0.140 |
Why?
|
| Mycological Typing Techniques | 1 | 2017 | 2 | 0.130 |
Why?
|
| Cluster Analysis | 1 | 2017 | 65 | 0.130 |
Why?
|
| Drug Resistance, Multiple | 1 | 2016 | 6 | 0.130 |
Why?
|
| Genotyping Techniques | 1 | 2017 | 38 | 0.130 |
Why?
|
| Aged, 80 and over | 2 | 2016 | 468 | 0.130 |
Why?
|
| Genetic Variation | 1 | 2017 | 175 | 0.120 |
Why?
|
| Adult | 4 | 2018 | 5913 | 0.100 |
Why?
|
| Hospitals | 2 | 2023 | 103 | 0.080 |
Why?
|
| Prospective Studies | 2 | 2023 | 1160 | 0.070 |
Why?
|
| Bacteria | 1 | 2023 | 47 | 0.050 |
Why?
|
| Gram-Positive Bacteria | 1 | 2022 | 9 | 0.050 |
Why?
|
| Gram-Negative Bacteria | 1 | 2022 | 15 | 0.050 |
Why?
|
| Young Adult | 2 | 2016 | 2498 | 0.040 |
Why?
|
| Geography | 1 | 2019 | 60 | 0.040 |
Why?
|
| Aspergillosis | 1 | 2018 | 1 | 0.040 |
Why?
|
| Itraconazole | 1 | 2018 | 1 | 0.040 |
Why?
|
| Logistic Models | 1 | 2019 | 254 | 0.040 |
Why?
|
| Immunocompromised Host | 1 | 2018 | 34 | 0.040 |
Why?
|
| RNA, Ribosomal, 28S | 1 | 2016 | 2 | 0.030 |
Why?
|
| Genome, Fungal | 1 | 2016 | 4 | 0.030 |
Why?
|
| Whole Genome Sequencing | 1 | 2016 | 44 | 0.030 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2016 | 25 | 0.030 |
Why?
|
| Global Health | 1 | 2016 | 193 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 198 | 0.030 |
Why?
|
| Mutation | 1 | 2016 | 306 | 0.030 |
Why?
|